PsP Specification

  • Availability: In Stock

Description : Each capsule contains 250 mg of polysaccharide peptide extract from Ganoderma lucidum mycelium

Active Constituent Analysis

SLH Product’s Specification/
Capsule

Method

Polysaccharides

(Consist of glucose, mannose, xylose, fucose, galactose and linked by b-glycosidic linkages)                                                  

min. 250 mg

Phenol Sulfuric Acid

β–1.3/1.6-D-Glucan content in Polysaccharides

min. 180 mg

Congo Red

Protein

min. 10 mg

Lowry

Heavy Metal

 

Hg

≤ 0.5 ppm

AAS

Cd

≤ 0.3 ppm

Pb

≤ 10 ppm

As

≤ 5 ppm

Typical Microbiological Analysis

 

Total bacterial count

< 30 cfu/g

USP Method 61

Total yeast and mould count

< 30 cfu/g

Salmonella Sp.

Negative

Indonesian Pharmacopeia 4th Ed. 1995

Escherichia coli

Negative

Staphylococcus aureus

Negative

Pseudomonas aeruginosa

Negative

Shigella Sp.

Negative

Culture & Identification

Physical Properties

 

Appearance

Powder

Organoleptic Test

Color

Yellow brown

Odor

Typical mushroom

Taste

Tasteless

Moisture Content

≤ 10 %

Indonesian Pharmacopeia 4th Ed. 1995

 

 

Packaging

1 bottle @ 30 capsules

Storage

Keep in dry and cool place, avoid direct sun contact


Document Number : SLH/SPESI/QC/04/001
The information contained herein is believed to be true and reliable.



 Download PDF